38.6c New Delhi, India, Saturday, August 02, 2025
Top Stories Supreme Court
Political NEWS Legislative Corner Celebstreet International Videos
Subscribe Contact Us
close
Business

Win for Pfizers Viagra trademark in Delhi HC against homeopathy remedy Vigoura [Read Judgment]

By Shreya Agarwal      03 May, 2024 05:19 PM      0 Comments
Win for Pfizers Viagra trademark in Delhi HC against homeopathy remedy Vigoura

NEW DELHI: In a win for Pfizer Products Inc.s trademark and brand name on its erectile dysfunction allopathy drug Viagra, the Delhi High Court has permanently restrained one Renovision Exports Pvt. Ltd. (REPL) from the use of the mark Vigoura for its homeopathy remedy for sexual disorders.

A single judge bench of Justice Sanjeev Narula also directed REPL to pay damages to Pfizer to the tune of Rs. 3 lakhs, alongwith litigation costs.

The bench directed that the Defendants (REPL) or anyone acting on their behalf are permanently restrained from manufacturing, selling, or offering for sale, marketing, advertising, or in any other manner using the mark Vigoura or any mark deceptively similar to the Plaintiffs (Pfizers) trademark Viagra in relation to any of their goods as would amount to infringement or passing off of the Plaintiffs  (Pfizers) registered mark Viagra.

Pfizer claimed that although Viagra was officially launched in the US in 1998 and in India only in 2005, its groundbreaking nature as a treatment for erectile dysfunction garnered extensive international media coverage from the outset.

The Court agreed that Pfizers strategic promotional activities at international medical and pharmaceutical conferences attended by professionals from around the world, including India, facilitated the permeation of Viagra reputation across national borders.

The Court also noted that the trademark Viagra is highly recognized by its name in the sphere of erectile dysfunction drugs, as demonstrated by documentary and oral evidence placed on record. They have invested heavily in building a brand and owing to its success, Viagra has acquired national and global repute.

The Court also rejected REPLs argument that there also exist multiple products with names similar to Vigoura, marketed in India much before Pfizers Viagra - such as Vigora, Vigourmalt, Vigor Plus, Vigora , etc - with the only difference being that the said marks have been registered in ayurvedic system of medicine or for a different pharmaceutical preparation. REPL argued that therefore it could not be said that its Vigoura was violative of law.

The Court refused to accept this argument stating that its a well-established principle that a trademark holders decision not to pursue legal action against third parties who may possess similar marks does not preclude them from obtaining an injunctive relief against a specific holder of a deceptive trademark.

Further, while REPL contended that there are significant differences in Viagras allopathic treatment and Vigouras homeopathy treatment, the Court held that unlike non-medicinal products, where confusion might only result in economic harm confusion between medicinal products can pose serious risks to public health.

Therefore, it held that it must apply rigorous standards in cases of similarities between medicinal products.

Justice Narula, therefore decided, In the given scenario, the differences between homeopathic and allopathic treatments becomes less relevant than the overarching need to prevent misleading impressions about the products origin or affiliation. Given the critical nature of the medicines involved, which are designed to address sensitive health issues, the potential for deception is not only high, but also fraught with serious implications for consumer health and safety.

Cause Title: Pfizer Products Inc. v Renovision Exports Pvt. Ltd. and Anr.
 

[Read Judgment]



Share this article:

About:

A wanderer, aspiring yogini and writer. Shreya is a lawyer by profession, journalist by passion. A g...Read more

Follow:
FacebookTwitterLinkedinInstagram


Leave a feedback about this
Related Posts
View All

'Without documentary proof, Waqf Board can't lay claim over any property' 'Without documentary proof, Waqf Board can't lay claim over any property'

In 2012, the Anjuman Committee addressed a letter to the Chairman of the Waqf Board stating there is a wall and Chabutrah (platform) on a 'Tiranga Ki Qalandari Masjid where in olden times laborers used to offer prayers.

Delhi High Court Sets Aside Arbitral Tribunal's Award Against NHAI in Highway Project Delay Case [Read Judgment] Delhi High Court Sets Aside Arbitral Tribunal's Award Against NHAI in Highway Project Delay Case [Read Judgment]

The Delhi High Court sets aside an Arbitral Tribunal's award favoring IRB Pathankot Amritsar Toll Road Ltd over a delay in a highway project. The court finds that the tribunal did not address the essential dispute of whether the National Highways Authority of India (NHAI) was in material default, rendering the award invalid.

Delhi Court Rejects Stay Request in Defamation Case Against Rajasthan CM Ashok Gehlot [Read Order] Delhi Court Rejects Stay Request in Defamation Case Against Rajasthan CM Ashok Gehlot [Read Order]

A Delhi court refuses to stay the defamation case filed by Union Cabinet minister Gajendra Singh Shekhawat against Rajasthan Chief Minister Ashok Gehlot. The court declined to stay the summons and sets a hearing date for August 19.

Delhi High Court to Commence Daily Hearings on August 28 for Appeals Against Acquittals in 2G Case Delhi High Court to Commence Daily Hearings on August 28 for Appeals Against Acquittals in 2G Case

Delhi High Court is set to begin day-to-day hearings from August 28 for appeals by CBI and ED against acquittals in the 2G spectrum allocation case, expressing displeasure over adjournment requests. The case involves former telecom minister A Raja and business entities. Learn about the proceedings and details of the case.

TRENDING NEWS

sc-to-first-consider-maintainability-of-review-against-2022-judgment-on-eds-powers-under-pmla
Trending Judiciary
SC to first consider maintainability of review against 2022 judgment on ED's powers under PMLA

SC to first decide if review pleas on ED powers under PMLA are maintainable; hearing on Karti Chidambaram’s plea set for August 6.

01 August, 2025 10:58 AM
sc-recalls-may-2-judgment-scrapping-jsw-steels-resolution-plan-for-bhushan-power-and-steel-ltd
Trending Business
SC recalls May 2 judgment scrapping JSW Steel's resolution plan for Bhushan Power and Steel Ltd

SC recalls its May 2 verdict cancelling JSW Steel’s ₹19,300 Cr resolution plan for Bhushan Power; matter to be heard afresh on August 7.

01 August, 2025 11:13 AM

TOP STORIES

sc-questions-justice-varma-over-failure-to-challenge-validity-of-in-house-inquiry-panel
Trending Judiciary
SC questions Justice Varma over failure to challenge validity of in-house inquiry panel

SC questions Justice Varma for not challenging in-house probe panel earlier despite cash haul case; asks why he joined inquiry if he found it flawed.

28 July, 2025 02:27 PM
timelines-for-governor-prez-to-clear-bills-kerala-asks-sc-to-return-presidential-reference-unanswered
Trending Executive
Timelines for Governor, Prez to clear Bills: Kerala asks SC to return presidential reference "unanswered"

Kerala urges SC to return Presidential reference on bill clearance timelines as “unmaintainable”, citing suppression of facts and settled SC rulings under Article 200.

28 July, 2025 02:38 PM
sc-refuses-to-stay-publication-of-draft-voters-list-in-bihar-on-aug-1
Trending Judiciary
SC refuses to stay publication of draft voters list in Bihar on Aug 1

SC declines stay on Bihar draft voter list; asks EC to consider Aadhaar, Voter ID for inclusion ahead of Assembly polls on August 1.

28 July, 2025 04:10 PM
why-so-many-students-dying-by-suicides-sc-asks-iit-kharagpur
Trending Judiciary
Why so many students dying by suicides, SC asks IIT Kharagpur

SC asks IIT Kharagpur why students are dying by suicide; raises concern amid rising campus deaths despite new mental health guidelines.

29 July, 2025 11:51 AM

ADVERTISEMENT


Join Group

Signup for Our Newsletter

Get Exclusive access to members only content by email